Abstract: The present invention facilitates in silico evaluation of molecules for biological activity by providing a computer-based method to predict whether oligonucleotides may possess biological activity and the efficacy of the biological activity based on the three-dimensional structure and charge characteristics of the oligonucleotides. Biological activities include, but are not limited to, cellular proliferation, induction of cell cycle arrest and apoptosis.
Type:
Grant
Filed:
August 19, 2002
Date of Patent:
April 3, 2007
Assignee:
Bionicrie Life Sciences, Inc.
Inventors:
Nigel C. Phillips, Mario C. Filion, Zdenek Richard Holan, Stéphanie Reader